| # | Title | Journal | Year | Citations |
|---|
| 1 | Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation | Thrombosis and Haemostasis | 2001 | 1,875 |
| 2 | A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy | Thrombosis and Haemostasis | 1993 | 1,658 |
| 3 | Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer | Thrombosis and Haemostasis | 2000 | 1,417 |
| 4 | Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity | Thrombosis and Haemostasis | 2010 | 1,330 |
| 5 | A Cell-based Model of Hemostasis | Thrombosis and Haemostasis | 2001 | 1,286 |
| 6 | Autologous platelets as a source of proteins for healing and tissue regeneration | Thrombosis and Haemostasis | 2004 | 1,189 |
| 7 | Venous thromboembolism (VTE) in Europe | Thrombosis and Haemostasis | 2007 | 1,100 |
| 8 | On the Regulation and Control of Fibrinolysis | Thrombosis and Haemostasis | 1980 | 995 |
| 9 | Criteria for the Diagnosis of Lupus Anticoagulants: An Update | Thrombosis and Haemostasis | 1995 | 886 |
| 10 | Incidence of Venous Thromboembolism: A Community-based Study in Western France | Thrombosis and Haemostasis | 2000 | 748 |
| 11 | Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation | Thrombosis and Haemostasis | 2001 | 709 |
| 12 | Identification and Biological Activity of the Active Metabolite of Clopidogrel | Thrombosis and Haemostasis | 2000 | 688 |
| 13 | Definitions in Hemophilia | Thrombosis and Haemostasis | 2001 | 679 |
| 14 | A Survey of 215 Non-Hemophilic Patients with Inhibitors to Factor VIII | Thrombosis and Haemostasis | 1981 | 678 |
| 15 | Geographic Distribution of the 20210 G to A Prothrombin Variant | Thrombosis and Haemostasis | 1998 | 675 |
| 16 | A method to determine the optimal intensity of oral anticoagulant therapy | Thrombosis and Haemostasis | 1993 | 659 |
| 17 | Platelet Factor 4 Complexed to Heparin Is the Target for Antibodies Generated in Heparin-Induced Thrombocytopenia | Thrombosis and Haemostasis | 1992 | 657 |
| 18 | Inherited Antithrombin Deficiency Causing Thrombophilia | Thrombosis and Haemostasis | 1965 | 634 |
| 19 | Brain-derived Neurotrophic Factor Is Stored in Human Platelets and Released by Agonist Stimulation | Thrombosis and Haemostasis | 2002 | 631 |
| 20 | Heparin-induced Thrombocytopenia: Towards Consensus | Thrombosis and Haemostasis | 1998 | 595 |
| 21 | Platelets, inflammation and tissue regeneration | Thrombosis and Haemostasis | 2011 | 593 |
| 22 | Cell-derived Microparticles Circulate in Healthy Humans and Support Low Grade Thrombin Generation | Thrombosis and Haemostasis | 2001 | 575 |
| 23 | The Nijmegen Modification of the Bethesda Assay for Factor VIII:C Inhibitors: Improved Specificity and Reliability | Thrombosis and Haemostasis | 1995 | 560 |
| 24 | COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure | Thrombosis and Haemostasis | 2020 | 553 |
| 25 | Safety of Low-Molecular-Weight Heparin in Pregnancy: A Systematic Review | Thrombosis and Haemostasis | 1999 | 544 |
| 26 | Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement | Thrombosis and Haemostasis | 2003 | 534 |
| 27 | Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality | Thrombosis and Haemostasis | 2007 | 531 |
| 28 | Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban | Thrombosis and Haemostasis | 2012 | 529 |
| 29 | The Incidence of Deep Venous Thrombosis and Pulmonary Embolism among Patients with Inflammatory Bowel Disease: A Population-based Cohort Study | Thrombosis and Haemostasis | 2001 | 517 |
| 30 | The Epidemiology of Venous Thromboembolism in the Community | Thrombosis and Haemostasis | 2001 | 515 |
| 31 | Haemostasis in Normal Pregnancy | Thrombosis and Haemostasis | 1984 | 502 |
| 32 | Inherited Thrombophilia: Part 1 | Thrombosis and Haemostasis | 1996 | 494 |
| 33 | The Structural Biology of Expression and Function of Tissue Factor | Thrombosis and Haemostasis | 1991 | 493 |
| 34 | A Revised Classification of von Willebrand Disease | Thrombosis and Haemostasis | 1994 | 491 |
| 35 | Lupus Anticoagulant IgG's (LA) Are Not Directed to Phospholipids only, but to a Complex of Lipid-Bound Human Prothrombin | Thrombosis and Haemostasis | 1991 | 485 |
| 36 | Determination of Human Thrombin-Antithrombin III Complex in Plasma with an Enzyme-Linked Immunosorbent Assay | Thrombosis and Haemostasis | 1988 | 483 |
| 37 | Impact, Diagnosis and Treatment of von Willebrand Disease | Thrombosis and Haemostasis | 2000 | 478 |
| 38 | Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures | Thrombosis and Haemostasis | 2003 | 477 |
| 39 | D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis | Thrombosis and Haemostasis | 2020 | 474 |
| 40 | Developmental haemostasis | Thrombosis and Haemostasis | 2006 | 466 |
| 41 | Platelet Activation and Blood Coagulation | Thrombosis and Haemostasis | 2002 | 460 |
| 42 | Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets | Thrombosis and Haemostasis | 2007 | 460 |
| 43 | Multiple electrode aggregometry: A new device to measure platelet aggregation in whole blood | Thrombosis and Haemostasis | 2006 | 456 |
| 44 | High Plasma Concentration of Factor VIIIc Is a Major Risk Factor for Venous Thromboembolism | Thrombosis and Haemostasis | 2000 | 448 |
| 45 | A Simple, Sensitive Spectrophotometric Assay for Extrinsic (Tissue-Type) Plasminogen Activator Applicable to Measurements in Plasma | Thrombosis and Haemostasis | 1982 | 442 |
| 46 | Assessment of laboratory assays to measure rivaroxaban – an oral, direct factor Xa inhibitor | Thrombosis and Haemostasis | 2010 | 436 |
| 47 | Transglutaminases: Protein Cross-Linking Enzymes in Tissues and Body Fluids | Thrombosis and Haemostasis | 1994 | 433 |
| 48 | Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry | Thrombosis and Haemostasis | 2008 | 417 |
| 49 | The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study | Thrombosis and Haemostasis | 2012 | 414 |
| 50 | Biochemistry and Physiology of Blood Coagulation | Thrombosis and Haemostasis | 1999 | 409 |
